Treatment of Fungal Blepharitis, Conjunctivitis, and Keratitis

NATACYN® is the first and only FDA approved ophthalmic anti-fungal with over 40 years of proven safety and efficacy. With over 27 countries relying on NATACYN® to treat fungal infections caused by susceptible organisms including Fusarium solani the World Health Organization (WHO) has placed NATACYN® on the Essential Medicines list.

Learn More

Eyevance® Pharmaceutical LLC has been acquired by Santen Pharmaceutical Co., Ltd. Natacyn® is a registered trademark of Eyevance Pharmaceutical.


Explore more products

PATIENT COPAY
PROGRAM

Learn More

SEE WHAT'S IN
OUR PIPELINE

Get Details

IMPORTANT SAFETY INFORMATION

INDICATIONS AND USAGE

NATACYN® (natamycin ophthalmic suspension) 5% is indicated for the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis.

IMPORTANT SAFETY INFORMATION

ADVERSE REACTIONS

The following events have been identified during post-marketing use of NATACYN® in clinical practice: allergic reaction, change in vision, chest pain, corneal opacity, dyspnea, eye discomfort, eye edema, eye hyperemia, eye irritation, eye pain, foreign body sensation, paresthesia, and tearing.

Please see the Full Prescribing Information.

IMPORTANT SAFETY INFORMATION

INDICATIONS AND USAGE

NATACYN® (natamycin ophthalmic suspension) 5% is indicated for the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis.

IMPORTANT SAFETY INFORMATION

ADVERSE REACTIONS:

The following events have been identified during post-marketing use of NATACYN® in clinical practice: allergic reaction, change in vision, chest pain, corneal opacity, dyspnea, eye discomfort, eye edema, eye hyperemia, eye irritation, eye pain, foreign body sensation, paresthesia, and tearing.

Please see the Full Prescribing Information.